Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:11217959 | ||||
Kosch M and Schaefer RM | [Iron deficiency. When parenteral substitution?]. | 2001 | MMW Fortschr Med | pmid:11247361 |
Breymann C et al. | Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11262469 |
pmid:11273875 | ||||
Stoves J et al. | A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. | 2001 | Nephrol. Dial. Transplant. | pmid:11328902 |
Talafant E et al. | Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment. | 1975 | Pediatr. Res. | pmid:1134846 |
Levy G et al. | Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. | 1975 | Pediatrics | pmid:1134883 |
pmid:11390726 | ||||
Pach J et al. | New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. | 2001 | Prz. Lek. | pmid:11450331 |
Prakash S et al. | Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | 2001 May-Jun | Perit Dial Int | pmid:11475345 |